Trial Profile
Post Marketing Surveillance Study for ONIVYDE in South Korea.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2021
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- Sponsors Shire; Takeda
- 27 Sep 2021 Status changed from recruiting to completed.
- 14 Mar 2018 Status changed from not yet recruiting to recruiting.
- 28 Feb 2018 New trial record